glycyrrhizic acid has been researched along with Breast Cancer in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Azzahra, SNA; Hanif, N; Hermawan, A | 1 |
| Ancion, M; Bruyere, D; Delvenne, P; Demoulin, S; Hendrick, E; Herfs, M; Hubert, P; Lebeau, A; Lerho, T; Meunier, M; Nokin, MJ; Peulen, O; Pilard, C; Radermecker, C; Reynders, C; Roncarati, P | 1 |
| Chen, LL; Chu, PY; Huang, CH; Li, CJ; Liao, WT; Lin, LT; Lin, SC; Tsui, KH; Wu, MY | 1 |
| Cheng, XL; Cui, XB; Li, P; Peng, GP; Peng, YB; Qi, LW; Ren, MT; Zheng, YF | 1 |
| Dong, S; Inoue, A; Kiyama, R; Tanji, M; Zhu, Y | 1 |
| Il'icheva, TN; Pokrovskiĭ, AG; Proniaeva, TR; Smetannikov, AA | 1 |
| Akimoto, M; Iwasaki, H; Kasai, M; Kimura, M; Matano, S; Nakajima, Y; Sawano, A | 1 |
7 other study(ies) available for glycyrrhizic acid and Breast Cancer
| Article | Year |
|---|---|
MDM2 is a Potential Target Gene of Glycyrrhizic Acid for Circumventing Breast Cancer Resistance to Tamoxifen: Integrative Bioinformatics Analysis.
Topics: Breast Neoplasms; Computational Biology; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glycyrrhizic Acid; Humans; Molecular Docking Simulation; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; Tamoxifen | 2022 |
Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy.
Topics: Adaptive Immunity; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Female; Glycyrrhizic Acid; HMGB1 Protein; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Peptide Fragments; RAW 264.7 Cells; S100 Proteins; Signal Transduction; Tumor Burden; Tumor Microenvironment; Uterine Cervical Neoplasms | 2021 |
Glycyrrhizic acid induces human MDA-MB-231 breast cancer cell death and autophagy via the ROS-mitochondrial pathway.
Topics: Antineoplastic Agents, Phytogenic; Autophagy; Autophagy-Related Proteins; Breast Neoplasms; Cell Cycle; Cell Proliferation; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Glycyrrhizic Acid; Humans; Membrane Potential, Mitochondrial; Mitochondria; Reactive Oxygen Species | 2018 |
Oleanane-type triterpene glucuronides from the roots of Glycyrrhiza uralensis Fischer.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Female; Glycyrrhiza; Glycyrrhizic Acid; HeLa Cells; Humans; Molecular Structure; Neoplasms; Phytotherapy; Plant Extracts; Plant Roots; Saponins; Structure-Activity Relationship | 2010 |
Activation of rapid signaling pathways and the subsequent transcriptional regulation for the proliferation of breast cancer MCF-7 cells by the treatment with an extract of Glycyrrhiza glabra root.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Estradiol; Extracellular Signal-Regulated MAP Kinases; Female; Glycyrrhiza; Glycyrrhizic Acid; Humans; Phytotherapy; Plant Extracts; Plant Roots; Proto-Oncogene Proteins c-akt; Signal Transduction | 2007 |
[Content of progesterone, glucocorticoid and glycyrrhizic acid receptors in normal and tumoral human breast tissue].
Topics: Breast; Breast Neoplasms; Cytoplasm; Female; Glycyrrhizic Acid; Humans; Protein Binding; Receptors, Glucocorticoid; Receptors, Progesterone | 1998 |
[Prevention of cancer chemotherapeutic agent-induced toxicity in postoperative breast cancer patients with glycyrrhizin (SNMC)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Humans; Leukopenia; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Postoperative Care; Tegafur | 1986 |